文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

临床宏基因组测序诊断脑膜炎与脑炎

Clinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis.
PubMed 文献 · N Engl J Med · 2019-01-01
一句话结论住院脑膜炎或脑炎患者中,脑脊液宏基因组NGS可检出常规临床检测未发现的神经侵袭性病原体,部分病例据此调整治疗。

该多中心前瞻性研究在8家医院纳入204例住院儿童和成人脑膜炎或脑炎患者,评估脑脊液宏基因组NGS的诊断价值。患者病情重,48.5%曾入住ICU,30天死亡率为11.3%。57例患者共诊断58例神经系统感染,其中13例(22%)仅由宏基因组NGS发现而源医院临床检测未检出,另19例与临床检测同时诊断。13例仅由宏基因组NGS诊断的感染中,8例可能有临床影响,7例指导了治疗。作者认为常规微生物检测常不足以发现所有神经侵袭性病原体,脑脊液宏基因组NGS改善了部分病例的诊断并提供可操作信息。

要点

  • 8家医院204例住院脑膜炎或脑炎患者中,57例(27.9%)共诊断58例神经系统感染。
  • 58例感染中13例(22%)仅由脑脊液宏基因组NGS检出,源医院临床检测未发现。
  • 45例(78%)临床检测阳性的感染中,宏基因组NGS同时诊断19例。
  • 13例仅由宏基因组NGS诊断的感染中,8例可能有临床影响,7例指导治疗。
  • 26例宏基因组NGS未检出的感染中,11例仅血清学诊断,7例依靠脑脊液以外的组织样本诊断,8例因脑脊液病原体滴度低而阴性。

适用人群与场景

  • 8家医院住院的儿童和成人脑膜炎或脑炎患者,共204例。
  • 患者病情重:48.5%曾入住ICU,30天死亡率为11.3%。

研究设计与关键结果

  • 研究类型:为期1年的多中心前瞻性研究;样本量204例;8家医院;人群为住院儿童和成人脑膜炎或脑炎患者。
  • 主要结果:57例患者共诊断58例神经系统感染(27.9%);其中13例(22%)仅由脑脊液宏基因组NGS检出,源医院临床检测未发现。
  • 其余45例(78%)临床检测阳性的感染中,宏基因组NGS同时诊断19例。
  • 26例宏基因组NGS未检出的感染中,11例仅血清学诊断,7例依靠脑脊液以外的组织样本诊断,8例因脑脊液病原体滴度低而阴性。
  • 13例仅由宏基因组NGS诊断的感染中,8例可能有临床影响,7例指导治疗。
  • 所有宏基因组NGS阳性病原体结果均经正交实验室检测确认;临床影响通过回顾性病历审查评估。

证据类型、等级与局限

  • 证据类型:多中心前瞻性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为常规微生物学检测常不足以检出所有神经侵袭性病原体。
  • 作者认为脑脊液宏基因组NGS改善了脑膜炎或脑炎患者神经系统感染的诊断,并在部分病例中提供了可操作信息。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Metagenomic next-generation sequencing (NGS) of cerebrospinal fluid (CSF) has the potential to identify a broad range of pathogens in a single test.

METHODS: In a 1-year, multicenter, prospective study, we investigated the usefulness of metagenomic NGS of CSF for the diagnosis of infectious meningitis and encephalitis in hospitalized patients. All positive tests for pathogens on metagenomic NGS were confirmed by orthogonal laboratory testing. Physician feedback was elicited by teleconferences with a clinical microbial sequencing board and by surveys. Clinical effect was evaluated by retrospective chart review.

RESULTS: We enrolled 204 pediatric and adult patients at eight hospitals. Patients were severely ill: 48.5% had been admitted to the intensive care unit, and the 30-day mortality among all study patients was 11.3%. A total of 58 infections of the nervous system were diagnosed in 57 patients (27.9%). Among these 58 infections, metagenomic NGS identified 13 (22%) that were not identified by clinical testing at the source hospital. Among the remaining 45 infections (78%), metagenomic NGS made concurrent diagnoses in 19. Of the 26 infections not identified by metagenomic NGS, 11 were diagnosed by serologic testing only, 7 were diagnosed from tissue samples other than CSF, and 8 were negative on metagenomic NGS owing to low titers of pathogens in CSF. A total of 8 of 13 diagnoses made solely by metagenomic NGS had a likely clinical effect, with 7 of 13 guiding treatment.

CONCLUSIONS: Routine microbiologic testing is often insufficient to detect all neuroinvasive pathogens. In this study, metagenomic NGS of CSF obtained from patients with meningitis or encephalitis improved diagnosis of neurologic infections and provided actionable information in some cases. (Funded by the National Institutes of Health and others; PDAID ClinicalTrials.gov number, NCT02910037.).

来源:N Engl J Med,查看原文。版权归原作者所有。

参考来源

  1. Wilson MR, Sample HA, Zorn KC, et al. Clinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis. N Engl J Med. 2019. PMID: 31189036. doi:10.1056/NEJMoa1803396

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。